ELVN
Enliven Therapeutics Inc.
44.80$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 92.0% | 99.5% | 97.7% | 93.3% | 97.9% | 97.7% | 99.7% | |
| 94.6% | 95.8% | 14.8% | 52.5% | 97.1% | 90.7% | 36.8% | 38.1% | 20.8% | |
| 94.6% | 95.8% | 86.8% | 97.1% | 97.1% | 90.7% | 93.1% | 96.2% | 97.2% | |
| – | – | – | 0.5% | 0.8% | – | – | – | – | |
| 14.5% | 23.8% | 13.2% | 7.1% | 5.7% | 192.2% | 9.5% | 4.9% | 3.5% | |
| 8.1% | 23.8% | 12.6% | 6.9% | 5.1% | 11.7% | 9.5% | 4.9% | 3.5% | |
| – | – | – | 0.1% | 0.1% | 0.4% | 0.1% | – | 0.1% | |
| 4.2% | 11.8% | 5.0% | 2.2% | 2.2% | 4.1% | 0.2% | 0.4% | 0.5% | |
| -152.0% | -341.5% | -146.7% | 92.9% | 94.3% | -92.2% | 90.5% | 95.1% | 96.5% | |
| -195.2% | -406.1% | -164.4% | -105.8% | -39.9% | -99.5% | -56.8% | -74.7% | -72.9% | |
| 42.3% | 56.1% | 13.0% | 4.8% | 6.9% | 7.5% | 13.1% | 14.5% | 11.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.